Alector (ALEC) EBITDA (2018 - 2026)
Alector (ALEC) posted quarterly EBITDA of -$24.9 million for Q1 2026, up 44.25% year-over-year from -$17.3 million in Q1 2025, and up 37.02% quarter-over-quarter from -$39.6 million in Q4 2025.
Alector (ALEC) EBITDA (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported EBITDA for 9 consecutive years, with -$24.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA rose 44.25% year-over-year to -$24.9 million; the TTM figure through Mar 2026 stood at -$136.2 million (up 6.68% YoY), while the FY2025 annual figure was -$156.0 million, down 7.59% from the prior year.
- EBITDA grew to -$24.9 million in Q1 2026 per ALEC's latest filing, from -$39.6 million in the prior quarter.
- Across five years, EBITDA topped out at $9.5 million in Q2 2022 and bottomed at -$55.4 million in Q4 2022.
- Historically, EBITDA has averaged -$36.2 million across 5 years, with a median of -$44.1 million in 2022.
- Annual changes were most pronounced in 2022 — EBITDA surged 117.13% — and 2024, when it tumbled 1170.72%.
- Alector's EBITDA stood at -$55.4 million in 2022, then gained by 14.4% to -$47.5 million in 2023, then jumped by 84.72% to -$7.2 million in 2024, then tumbled by 445.81% to -$39.6 million in 2025, then surged by 37.02% to -$24.9 million in 2026.
- Business Quant data shows ALEC's EBITDA at -$24.9 million in Q1 2026, -$39.6 million in Q4 2025, and -$37.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | -24.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -24.39 Mn |
| Mar 31, 2026 | -24.92 Mn |
| Dec 31, 2025 | -39.57 Mn |
| Sep 30, 2025 | -37.61 Mn |
| Jun 30, 2025 | -34.14 Mn |
| Mar 31, 2025 | -44.70 Mn |
| Dec 31, 2024 | -7.25 Mn |
| Sep 30, 2024 | -48.43 Mn |
| Jun 30, 2024 | -45.61 Mn |
| Mar 31, 2024 | -43.71 Mn |
| Dec 31, 2023 | -47.45 Mn |
| Sep 30, 2023 | -50.58 Mn |
| Jun 30, 2023 | -3.59 Mn |
| Mar 31, 2023 | -50.12 Mn |
| Dec 31, 2022 | -55.44 Mn |
| Sep 30, 2022 | -47.75 Mn |
| Jun 30, 2022 | 9.48 Mn |
| Mar 31, 2022 | -44.12 Mn |
| Dec 31, 2021 | -55.73 Mn |
| Sep 30, 2021 | 126.33 Mn |